Atlas Trials

A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Clinical trial NCT01036009 · COMPLETED

Trial details

NCT number
NCT01036009
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBiphenotypic LeukemiaPre-leukemic SyndromesMonosomy 7Bone Marrow Clonal MalformationsJuvenile Myelomonocytic LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia
Start date
2009-10-01
Primary completion
2014-07-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.